KeyBank National Association
INFI

KeyBank National Association’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

KeyBank National Association’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-67,789
Closed -$142K – 1079
2018
Q1 		$142K Buy
+67,789
New +$145K ﹤0.01% 1014

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KeyBank National Association's INFI Position: Q2 2018 in Review

KeyBank National Association sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2018, closing a stake of 67,789 shares — an estimated $142K sold.

KeyBank National Association first reported a position in INFI in Q1 2018 and held it in 1 quarter. The position peaked at $142K in Q1 2018. 64 funds tracked by Wall St. Rank hold INFI as of Q2 2018.

  • KeyBank National Association reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • KeyBank National Association sold 67,789 Infinity Pharmaceuticals, Inc. shares in Q2 2018, an estimated $142K.
  • KeyBank National Association first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
  • KeyBank National Association's Infinity Pharmaceuticals, Inc. position peaked at $142K in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2018.

Based on KeyBank National Association's 13F filing for Q2 2018, filed 8 Aug 2018.